ezogabine has been researched along with levobupivacaine in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (levobupivacaine) | Trials (levobupivacaine) | Recent Studies (post-2010) (levobupivacaine) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 959 | 507 | 537 |
| Protein | Taxonomy | ezogabine (IC50) | levobupivacaine (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.1964 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cheng, Y; Duan, R; Li, H; Li, J; Yuan, J; Zhao, S | 1 |
1 other study(ies) available for ezogabine and levobupivacaine
| Article | Year |
|---|---|
Effectiveness of retigabine against levobupivacaine-induced central nervous system toxicity: a prospective, randomized animal study.
Topics: Animals; Anticonvulsants; Bupivacaine; Carbamates; Central Nervous System; KCNQ2 Potassium Channel; Levobupivacaine; Neurons; Phenylenediamines; Prospective Studies; Rabbits; Random Allocation; Seizures | 2016 |